In Stock

TiterSafe Influenza A (H5N1), American Wigeon/SC/22-000345-001/2021

SKU:
HAP-1214
Maximum Purchase:
10 units
Current Stock:
Virus (Subtype):
Influenza A (H5N1)
Strain:
A/American Wigeon/SC/22-000345-001/2021
Unit:
200µL
Lead Time:
Ready to ship
$755.00
Request a quote, including discounts on bulk orders
HA assay performed using 1% Guinea Pig RBCs in a 96-well plate. TiterSafe was treated with and without 5ug/ml Oseltamivir to counteract NA activity, which may interfere with the TiterSafe-RBC lattice at high TiterSafe concentrations. The HA assay was used to determine an Influenza A TiterSafe titer at 4 HA units.
TiterSafe by Integral Molecular, Inc.

Frequently Bought Together:

HA assay performed using 1% Guinea Pig RBCs in a 96-well plate. TiterSafe was treated with and without 5ug/ml Oseltamivir to counteract NA activity, which may interfere with the TiterSafe-RBC lattice at high TiterSafe concentrations. The HA assay was used to determine an Influenza A TiterSafe titer at 4 HA units.
Inc. Tax
Ex. Tax

Influenza TiterSafe, an HAI reagent, consists of non-replicative virus-like particles (VLPs) that display influenza HA and NA on a lentivirus core. TiterSafe replaces live virus in the hemagglutination inhibition assay (HAI), the standard assay for testing immune sera to determine to assess serum antibody titers. Protocols are provided for HA and HAI assays, with guinea pig RBCs the recommended target.

Product TiterSafe Hemagglutinating Particles, Influenza A
Catalog Number HAP-1214
Subtype H5N1
Strain American Wigeon/SC/22-000345-001/2021
Expected Dilution to 4HA units 1:64
Red Blood Cells (Not Included) Guinea Pig RBCs
Lead time Ready to ship
Shipping Shipped on dry ice
Storage conditions Store at ≤ -80°C upon receipt
Size 200µL/vial
Packaging DMEM

Related Products